JG
Jaison George
About Jaison George
Data last updated:
Jaison George is a Director at Kainopharm Limited (since 2020), Director at Hindustan Bio Sciences Limited (since 2023) and Designated Partner at Aiwon Life Sciences Llp (since 2019), and holds 1 more current directorship. The companies operate in Pharma, Chemicals and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹3.48 Cr; the largest is Kainopharm Limited at ₹2.66 Cr (FY 2025). Earlier, Jaison George was a Managing Director at Megasys Biotek Private Limited (2005–2017) and Director at Harvey Laboratories Private Limited (2006–2014) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Aug 2020 | 2020 | ₹2.66 Cr (FY 2025) | Active | |
| Director | 31 Oct 2023 | 1991 | ₹81.3 Lakh (FY 2025) | Active | |
| Designated Partner | 19 Jul 2019 | 2019 | Active | ||
| Director | 21 Jul 2009 | 2009 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 01 Feb 2005 | 2005 | ₹18.53 Cr (FY 2025) | Active | |
| Director | 08 Sep 2006 | 2006 | ₹15.52 Cr (FY 2023) | Active | |
| Director | 28 Mar 1996 | 1996 | ₹35,668 (FY 2018) | Strike Off | |
| Director | 19 Jan 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jaison George
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jaison George
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jaison George
Jaison George currently holds 4 directorships: Kainopharm Limited (Director, since 19 Aug 2020, revenue ₹2.66 Cr (FY 2025)); Hindustan Bio Sciences Limited (Director, since 31 Oct 2023, revenue ₹81.3 Lakh (FY 2025)); Aiwon Life Sciences Llp (Designated Partner, since 19 Jul 2019); Harvey Life Sciences Private Limited (Director, since 21 Jul 2009).
Jaison George was first appointed on 28 Mar 1996 as Director at Harvey Formulations Private Limited. The most recent appointment on record is 31 Oct 2023 at Hindustan Bio Sciences Limited.
The 2 current companies of Jaison George that report revenue have a combined latest revenue of ₹3.48 Cr: Kainopharm Limited ₹2.66 Cr (FY 2025); Hindustan Bio Sciences Limited ₹81.3 Lakh (FY 2025).
Jaison George held 4 earlier board appointments: Megasys Biotek Private Limited (Managing Director, 01 Feb 2005 to 20 Jun 2017); Harvey Laboratories Private Limited (Director, 08 Sep 2006 to 24 Mar 2014); Harvey Formulations Private Limited (Director, 28 Mar 1996 to 24 Dec 2009); Doc & Med Healthcare Private Limited (Director, from 19 Jan 2012).
The current boards of Jaison George's companies include Abdul Latheef (Kainopharm Limited), Anilkumar Bhaskaran Nair (Kainopharm Limited), Anitha (Kainopharm Limited), Attupuram Sreekumar (Kainopharm Limited), Kuzhalmannam Lakshminarayanan Sreeram (Kainopharm Limited), Mohanakurup Anjiliparambil Narayanapillai (Kainopharm Limited), among others.